| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $8,967,672 | +10,321 | +56% | $868.88 | 28,838 | 10 Feb 2025 | Direct | |
| holding | LLY | Common Stock | 14,700 | 10 Feb 2025 | By Anat Hakim SLAT | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +6,700 | $0.000000 | 6,700 | 10 Feb 2025 | Common Stock | 6,700 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |